Tempest Therapeutics, Inc. (OVAS) [Rocket]

In millions, except per share items	Jun-30-23	Mar-31-23	Dec-31-22	Sep-30-22	Jun-30-22	Mar-31-22	Dec-31-21	Sep-30-21
	10-Q	10-Q	10-K	10-Q	10-Q	10-Q	10-K	10-Q
Assets [Abstract]
Current assets:
Cash and cash equivalents	17.6	22.9	31.2	42.8	51.6	45.8	51.8	59.7
Insurance recovery of legal settlement		0.5	0.5	15.2	15.0	15.0	15.0
Prepaid expenses and other current assets	1.3	1.7	1.5	3.2	2.5	2.6	2.7	3.5
Total current assets	18.5	24.7	33.0	60.3	68.3	62.7	69.0	62.6
Property and equipment-net	1.0	1.0	1.1	0.9	1.0	1.0	1.1	1.1
Operating lease right-of-use assets	10.8	11.2	11.7	1.3	1.6	2.7	3.1
Other noncurrent assets	0.4	0.4	0.4	0.7	0.5	0.5	0.1	0.1
Total assets	30.7	37.3	46.1	63.2	71.4	67.0	73.2	67.1

Liabilities and Equity [Abstract]
Liabilities [Abstract]
Current liabilities:
Accounts payable	0.9	1.2	1.1	0.9	1.4	0.7	1.0	2.4
Accrued legal settlement		0.5	0.5	15.2	15.0	15.0	15.0
Accrued expenses	2.5	2.5	3.0	16.1	15.6	15.3	15.9	1.7
Current loan payable	3.0	1.5
Current operating lease liabilities	1.4	1.3	1.4	0.9	1.1	1.5	1.4
Accrued compensation	0.8	0.5	1.2	0.9	0.6	0.3	0.9	0.7
Interest payable	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
Total current liabilities	8.6	7.5	7.3	24.1	22.4	20.8	20.0	6.2
Loan payable (net of discount and issuance costs of $263 and $454, respectively)	7.5	8.9	10.4	11.8	13.3	15.1	15.1	15.0
Operating lease liabilities, less current portion	9.6	9.9	10.3	0.5	0.7		2.0
Total liabilities	25.7	26.4	28.0	36.4	36.4	37.6	37.1	23.6

Commitments and contingencies (Note 5)
Stockholders' equity:
Common stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Additional paid-in capital	156.0	154.4	153.9	153.4	152.6	137.9	136.2	135.9
Accumulated deficit	-151.0	-143.4	-135.8	-126.7	-117.7	-108.6	-100.1	-92.3
Total stockholders’ equity	5.0	11.0	18.1	26.8	34.9	29.4	36.1	43.5
Total liabilities and stockholders’ equity	30.7	37.3	46.1	63.2	71.4	67.0	73.2	67.1